PaxMedica, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 14.8 million compared to USD 10.23 million a year ago. Basic loss per share from continuing operations was USD 28.73 compared to USD 26.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.312 USD | -2.80% | -5.51% | -58.78% |
05-13 | PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-06 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.78% | 2.43M | |
+51.85% | 57.87B | |
+41.65% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- PXMD Stock
- News PaxMedica, Inc.
- PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022